Combination Nintedanib and Pirfenidone for Treatment of Idiopathic Pulmonary Fibrosis

被引：2
|
作者：
Rajchgot, Jason [1 ]
Stanbrook, Matthew B. [2 ]
Anand, Anju [3 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Toronto Western Hosp, Toronto, ON, Canada
[3] St Michaels Hosp, Toronto, ON, Canada
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 198卷 / 08期
关键词：
D O I：
10.1164/rccm.201805-0954LE
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
下载
收藏
页码：1105 / 1105
页数：1
相关论文
共 50 条
  • [1] Pirfenidone and Nintedanib for Treatment of Idiopathic Pulmonary Fibrosis
    Sathiyamoorthy, Gayathri
    Sehgal, Sameep
    Ashton, Rendell W.
    SOUTHERN MEDICAL JOURNAL, 2017, 110 (06) : 393 - 398
  • [2] Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
    Flaherty, Kevin R.
    Fell, Charlene D.
    Huggins, J. Terrill
    Nunes, Hilario
    Sussman, Robert
    Valenzuela, Claudia
    Petzinger, Ute
    Stauffer, John L.
    Gilberg, Frank
    Bengus, Monica
    Wijsenbeek, Marlies
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (02)
  • [3] Efficacy and safety of combination therapy with pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis
    Huh, Jin-Young
    Lee, Jae Ha
    Song, Jin Woo
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [4] Real World Experience of Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis
    Mulholland, S. A.
    Al Jbour, K.
    Steer, H.
    Gutsche, M.
    Foley, N.
    Srivastava, R.
    Sharp, C.
    Adamali, H. I.
    Barratt, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [5] TREATMENT COST COMPARISON OF PIRFENIDONE VERSUS NINTEDANIB ON THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
    Ho, R.
    Rufino, C.
    Lisondo, C.
    Alves, M.
    VALUE IN HEALTH, 2017, 20 (09) : A893 - A893
  • [6] Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis
    Ogura, Takashi
    Taniguchi, Hiroyuki
    Azuma, Arata
    Inoue, Yoshikazu
    Kondoh, Yasuhiro
    Hasegawa, Yoshinori
    Bando, Masashi
    Abe, Shinji
    Mochizuki, Yoshiro
    Chida, Kingo
    Klueglich, Matthias
    Fujimoto, Tsuyoshi
    Okazaki, Kotaro
    Tadayasu, Yusuke
    Sakamoto, Wataru
    Sugiyama, Yukihiko
    EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (05) : 1382 - 1392
  • [7] Pulmonary Fibrosis: Combination of nintedanib and pirfenidone safe and effective?
    Simon, Annika
    PNEUMOLOGIE, 2018, 72 (07): : 487 - 487
  • [8] Nintedanib and pirfenidone for the treatment of idiopathic pulmonary fibrosis: current and future perspectives.
    Leonardo Galindo, Javier
    Andres Celis, Carlos
    Mejia, Mayra
    INVESTIGACION CLINICA, 2018, 59 (04): : 369 - 385
  • [9] COST EFFECTIVENESS OF NINTEDANIB VERSUS PIRFENIDONE TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS IN TURKEY
    Demir, O.
    Tetik, E.
    Kamaci, E.
    Cheynel, J.
    VALUE IN HEALTH, 2017, 20 (09) : A646 - A646
  • [10] Nintedanib and Pirfenidone as a Bridge to Lung Transplant in Idiopathic Pulmonary Fibrosis
    Li, D.
    Mason, W.
    Hoy, H.
    Robbins, I.
    Loyd, J.
    Lancaster, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
12345